4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine

C328H213N25 — CID 159365137

IUPAC4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine
SMILESCn1c(-c2ccccc2)nc2c(-c3ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc3)cccc21.c1ccc(-n2c(-c3ccc(-c4ccc(-c5cc6c7ccccc7c(-c7ccc(-c8ccc(-c9nc%10ccccc%10n9-c9ccccc9)cc8)cc7)cc6c6ccccc56)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5cc6c7ccccc7c(-c7ccc(-c8ccc(-c9nc%10cncnc%10n9-c9ccccc9)cc8)cc7)cc6c6ccccc56)cc4)cc3)nc3cncnc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccccc3-c3ccc4c(ccc5c6ccccc6ccc45)c3)nc3ccccc32)cc1.c1ccc(N(c2ccccc2)c2ncnc3c2nc(-c2ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc2)n3-c2ccccc2)cc1
InChIInChI=1S/C68H44N4.C64H40N8.C47H31N5.C38H26N2.3C37H24N2/c1-3-15-53(16-4-1)71-65-25-13-11-23-63(65)69-67(71)51-39-31-47(32-40-51)45-27-35-49(36-28-45)59-43-61-58-22-10-8-20-56(58)60(44-62(61)57-21-9-7-19-55(57)59)50-37-29-46(30-38-50)48-33-41-52(42-34-48)68-70-64-24-12-14-26-66(64)72(68)54-17-5-2-6-18-54;1-3-11-49(12-4-1)71-61(69-59-37-65-39-67-63(59)71)47-31-23-43(24-32-47)41-19-27-45(28-20-41)55-35-57-54-18-10-8-16-52(54)56(36-58(57)53-17-9-7-15-51(53)55)46-29-21-42(22-30-46)44-25-33-48(34-26-44)62-70-60-38-66-40-68-64(60)72(62)50-13-5-2-6-14-50;1-4-13-37(14-5-1)51(38-15-6-2-7-16-38)46-44-47(49-31-48-46)52(39-17-8-3-9-18-39)45(50-44)34-22-20-32(21-23-34)35-25-27-41-36(30-35)26-29-42-40-19-11-10-12-33(40)24-28-43(41)42;1-40-36-13-7-12-33(37(36)39-38(40)28-9-3-2-4-10-28)27-16-14-25(15-17-27)29-19-21-32-30(24-29)20-23-34-31-11-6-5-8-26(31)18-22-35(32)34;1-2-11-28(12-3-1)39-36-17-9-8-16-35(36)38-37(39)34-15-7-6-14-30(34)26-19-21-31-27(24-26)20-23-32-29-13-5-4-10-25(29)18-22-33(31)32;1-2-12-30(13-3-1)39-36-16-7-6-15-35(36)38-37(39)29-11-8-10-26(24-29)27-18-20-32-28(23-27)19-22-33-31-14-5-4-9-25(31)17-21-34(32)33;1-2-9-30(10-3-1)39-36-13-7-6-12-35(36)38-37(39)27-16-14-25(15-17-27)28-19-21-32-29(24-28)20-23-33-31-11-5-4-8-26(31)18-22-34(32)33/h1-44H;1-40H;1-31H;2-24H,1H3;3*1-24H
InChIKeyLJAKVGMIOMHFGV-UHFFFAOYSA-N
MW4504.49 g/mol
LogP84.80
Rot. Bonds34

About 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine

4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine (PubChem CID 159365137) has the molecular formula C328H213N25 and a molecular weight of 4504.49 g/mol. Its IUPAC name is 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine.

Molecular Properties

Compound Name4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine
PubChem CID159365137
Molecular FormulaC328H213N25
Molecular Weight4504.49 g/mol
Exact Mass4500.74
IUPAC Name4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine
SMILESCn1c(-c2ccccc2)nc2c(-c3ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc3)cccc21.c1ccc(-n2c(-c3ccc(-c4ccc(-c5cc6c7ccccc7c(-c7ccc(-c8ccc(-c9nc%10ccccc%10n9-c9ccccc9)cc8)cc7)cc6c6ccccc56)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5cc6c7ccccc7c(-c7ccc(-c8ccc(-c9nc%10cncnc%10n9-c9ccccc9)cc8)cc7)cc6c6ccccc56)cc4)cc3)nc3cncnc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccccc3-c3ccc4c(ccc5c6ccccc6ccc45)c3)nc3ccccc32)cc1.c1ccc(N(c2ccccc2)c2ncnc3c2nc(-c2ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc2)n3-c2ccccc2)cc1
InChIInChI=1S/C68H44N4.C64H40N8.C47H31N5.C38H26N2.3C37H24N2/c1-3-15-53(16-4-1)71-65-25-13-11-23-63(65)69-67(71)51-39-31-47(32-40-51)45-27-35-49(36-28-45)59-43-61-58-22-10-8-20-56(58)60(44-62(61)57-21-9-7-19-55(57)59)50-37-29-46(30-38-50)48-33-41-52(42-34-48)68-70-64-24-12-14-26-66(64)72(68)54-17-5-2-6-18-54;1-3-11-49(12-4-1)71-61(69-59-37-65-39-67-63(59)71)47-31-23-43(24-32-47)41-19-27-45(28-20-41)55-35-57-54-18-10-8-16-52(54)56(36-58(57)53-17-9-7-15-51(53)55)46-29-21-42(22-30-46)44-25-33-48(34-26-44)62-70-60-38-66-40-68-64(60)72(62)50-13-5-2-6-14-50;1-4-13-37(14-5-1)51(38-15-6-2-7-16-38)46-44-47(49-31-48-46)52(39-17-8-3-9-18-39)45(50-44)34-22-20-32(21-23-34)35-25-27-41-36(30-35)26-29-42-40-19-11-10-12-33(40)24-28-43(41)42;1-40-36-13-7-12-33(37(36)39-38(40)28-9-3-2-4-10-28)27-16-14-25(15-17-27)29-19-21-32-30(24-29)20-23-34-31-11-6-5-8-26(31)18-22-35(32)34;1-2-11-28(12-3-1)39-36-17-9-8-16-35(36)38-37(39)34-15-7-6-14-30(34)26-19-21-31-27(24-26)20-23-32-29-13-5-4-10-25(29)18-22-33(31)32;1-2-12-30(13-3-1)39-36-16-7-6-15-35(36)38-37(39)29-11-8-10-26(24-29)27-18-20-32-28(23-27)19-22-33-31-14-5-4-9-25(31)17-21-34(32)33;1-2-9-30(10-3-1)39-36-13-7-6-12-35(36)38-37(39)27-16-14-25(15-17-27)28-19-21-32-29(24-28)20-23-33-31-11-5-4-8-26(31)18-22-34(32)33/h1-44H;1-40H;1-31H;2-24H,1H3;3*1-24H
InChIKeyLJAKVGMIOMHFGV-UHFFFAOYSA-N
XLogP84.80
TPSA240.96 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds34
Heavy Atoms353
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5004504.49
LogP ≤ 584.80
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Analyze 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[4-[3-(1,2-diphenylbenzimidazol-4-yl)phenyl]phenyl]-N-phenanthren-9-ylphenanthren-9-amine;N-[4-[3-(1,2-diphenylbenzimidazol-5-yl)phenyl]phenyl]-N-phenanthren-9-ylphenanthren-9-amine;N-[4-[3-(2,3-diphenylbenzimidazol-4-yl)phenyl]phenyl]-N-phenanthren-9-ylphenanthren-9-amine;N-[4-[3-(2,3-diphenylbenzimidazol-5-yl)phenyl]phenyl]-N-phenanthren-9-ylphenanthren-9-amine;N-phenanthren-9-yl-N-[4-[3-(2-phenylbenzimidazol-1-yl)phenyl]phenyl]phenanthren-9-amine
CID 159583043
N-[4-[3-(2-phenylbenzimidazol-1-yl)phenyl]phenyl]-N-(4-phenylphenyl)phenanthren-2-amine
CID 122425024
N-[4-[3-(1,2-diphenylbenzimidazol-5-yl)phenyl]phenyl]-N-phenanthren-2-ylphenanthren-2-amine
CID 122424886
N,N-bis[4-[3-(1,2-diphenylbenzimidazol-4-yl)phenyl]phenyl]naphthalen-1-amine
CID 122424896
N-[4-[3-(2,3-diphenylbenzimidazol-4-yl)phenyl]phenyl]-N-(4-phenylphenyl)phenanthren-2-amine
CID 122424952
2-[4-(1,8-diphenylphenanthren-3-yl)phenyl]-1-phenylbenzimidazole
CID 175392622
N-[4-[3-(1,2-diphenylbenzimidazol-4-yl)phenyl]phenyl]-4-(4-phenylphenyl)-N-[4-(4-phenylphenyl)phenyl]aniline
CID 122425006
5-chrysen-6-yl-1-methyl-2-phenylbenzimidazole;2-(1,2-diphenylbenzimidazol-5-yl)benzo[h]quinoline;3-(1,2-diphenylbenzimidazol-5-yl)phenanthro[9,10-b]pyrazine;1-methyl-5-phenanthren-9-yl-2-phenylbenzimidazole
CID 159576034
5-(9,10-diphenylanthracen-2-yl)-1-methyl-2-phenylbenzimidazole;2-(3-phenanthren-9-yl-5-pyridin-3-ylphenyl)-4,6-diphenyl-1,3,5-triazine;2-phenyl-4-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]benzo[h]quinazoline
CID 157098601
N,N-diphenyl-3-[2-[4-(1-phenylbenzimidazol-2-yl)phenyl]naphthalen-1-yl]aniline
CID 174262436
2-(4-benzo[a]anthracen-4-ylphenyl)-1-phenylbenzimidazole
CID 59412563
1-N,6-N-diphenyl-1-N,6-N-bis(4-trimethylgermylphenyl)pyrene-1,6-diamine;2-[4-[3-(10-naphthalen-2-ylanthracen-9-yl)naphthalen-1-yl]phenyl]-1-phenylbenzimidazole;9-naphthalen-1-yl-10-(4-naphthalen-2-ylphenyl)anthracene
CID 159913832

Frequently Asked Questions

What is the IUPAC name of 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine?
The IUPAC name of 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine (CID 159365137) is 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine.
What is the SMILES notation for 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine?
The canonical SMILES for 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine is Cn1c(-c2ccccc2)nc2c(-c3ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc3)cccc21.c1ccc(-n2c(-c3ccc(-c4ccc(-c5cc6c7ccccc7c(-c7ccc(-c8ccc(-c9nc%10ccccc%10n9-c9ccccc9)cc8)cc7)cc6c6ccccc56)cc4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc(-c5cc6c7ccccc7c(-c7ccc(-c8ccc(-c9nc%10cncnc%10n9-c9ccccc9)cc8)cc7)cc6c6ccccc56)cc4)cc3)nc3cncnc32)cc1.c1ccc(-n2c(-c3ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc3)nc3ccccc32)cc1.c1ccc(-n2c(-c3cccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)c3)nc3ccccc32)cc1.c1ccc(-n2c(-c3ccccc3-c3ccc4c(ccc5c6ccccc6ccc45)c3)nc3ccccc32)cc1.c1ccc(N(c2ccccc2)c2ncnc3c2nc(-c2ccc(-c4ccc5c(ccc6c7ccccc7ccc56)c4)cc2)n3-c2ccccc2)cc1.
What is the InChIKey of 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine?
The InChIKey is LJAKVGMIOMHFGV-UHFFFAOYSA-N. The full InChI is InChI=1S/C68H44N4.C64H40N8.C47H31N5.C38H26N2.3C37H24N2/c1-3-15-53(16-4-1)71-65-25-13-11-23-63(65)69-67(71)51-39-31-47(32-40-51)45-27-35-49(36-28-45)59-43-61-58-22-10-8-20-56(58)60(44-62(61)57-21-9-7-19-55(57)59)50-37-29-46(30-38-50)48-33-41-52(42-34-48)68-70-64-24-12-14-26-66(64)72(68)54-17-5-2-6-18-54;1-3-11-49(12-4-1)71-61(69-59-37-65-39-67-63(59)71)47-31-23-43(24-32-47)41-19-27-45(28-20-41)55-35-57-54-18-10-8-16-52(54)56(36-58(57)53-17-9-7-15-51(53)55)46-29-21-42(22-30-46)44-25-33-48(34-26-44)62-70-60-38-66-40-68-64(60)72(62)50-13-5-2-6-14-50;1-4-13-37(14-5-1)51(38-15-6-2-7-16-38)46-44-47(49-31-48-46)52(39-17-8-3-9-18-39)45(50-44)34-22-20-32(21-23-34)35-25-27-41-36(30-35)26-29-42-40-19-11-10-12-33(40)24-28-43(41)42;1-40-36-13-7-12-33(37(36)39-38(40)28-9-3-2-4-10-28)27-16-14-25(15-17-27)29-19-21-32-30(24-29)20-23-34-31-11-6-5-8-26(31)18-22-35(32)34;1-2-11-28(12-3-1)39-36-17-9-8-16-35(36)38-37(39)34-15-7-6-14-30(34)26-19-21-31-27(24-26)20-23-32-29-13-5-4-10-25(29)18-22-33(31)32;1-2-12-30(13-3-1)39-36-16-7-6-15-35(36)38-37(39)29-11-8-10-26(24-29)27-18-20-32-28(23-27)19-22-33-31-14-5-4-9-25(31)17-21-34(32)33;1-2-9-30(10-3-1)39-36-13-7-6-12-35(36)38-37(39)27-16-14-25(15-17-27)28-19-21-32-29(24-28)20-23-33-31-11-5-4-8-26(31)18-22-34(32)33/h1-44H;1-40H;1-31H;2-24H,1H3;3*1-24H.
What are the key properties of 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine?
4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine has a molecular weight of 4504.49 g/mol, XLogP of 84.80, 34 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(4-chrysen-2-ylphenyl)-1-methyl-2-phenylbenzimidazole;2-(2-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(3-chrysen-2-ylphenyl)-1-phenylbenzimidazole;2-(4-chrysen-2-ylphenyl)-1-phenylbenzimidazole;8-(4-chrysen-2-ylphenyl)-N,N,9-triphenylpurin-6-amine;1-phenyl-2-[4-[4-[12-[4-[4-(1-phenylbenzimidazol-2-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]benzimidazole;9-phenyl-8-[4-[4-[12-[4-[4-(9-phenylpurin-8-yl)phenyl]phenyl]chrysen-6-yl]phenyl]phenyl]purine is sourced from PubChem (CID 159365137), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).